Tag: Nasdaq:OYST
Oyster Point Pharma Announces Clinical Data Presentation of OC-01 (varenicline) Nasal...
PRINCETON, N.J., May 01, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the...